Ophthalmic device company has closed a $4m series A round to further develop its STARflo device, an implant for glaucoma, preparation for a US launch.
Capricorn Health-Tech Fund NV (CHF) and Societe Regionale d’Investissement de Wallonie (SRIW) have co led a $4m series A round of financing into Belgium-based iStar Medical, which spun out of Healionics Corporation with support from Belgium’s Region Wallonne government in 2010. There was also involvement from Financière Spin-off Luxembourgeoise and Namur Invest in the round
The new funds will be used to support further clinical trials of iStar’s tSTARflo, an implant for glaucoma.
